Analyst picks & changes

The Liposome Co. Inc.

(LIPO)

Liposome Technology Inc.

(LTIZ)

NeXstar Inc.

(NXTR)

Based on a comparison of the three companies' lipid-based amphotericin B products to treat fungal infections, UBS Securities analyst Marc Ostro said that he expects LIPO's

Read the full 388 word article

How to gain access

Continue reading with a
two-week free trial.